Trial Profile
A prospective, randomized, double-blind, placebo-controlled, phase III, multicenter trial to compare the safety, tolerability, immunogenicity and efficacy of three dose levels of a liquid formulation of influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Jul 2007
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors MedImmune
- 09 Dec 2005 New trial record.